Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin-Reference-Cited by-同舟云学术

Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin

Published:2012-02-15 Issue:5 Volume:65 Page:229-236
ISSN:0021-8820
Container-title:The Journal of Antibiotics
language:en
Short-container-title:J Antibiot

Author:

Shi Gongming,Chen Xiangdong,Wang Hui,Wang Siwen,Guo Xin,Zhang Xulei

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology

Link

http://www.nature.com/articles/ja20127.pdf

Reference29 articles.

1. Kuehnert, M. J. et al. Methicillin-resistant-Staphylococcusaureus hospitalizations, United States. Emerg. Infect. Dis. 11, 868–872 (2005).

2. Iyer, S. & Jones, D. H. Community-acquired methicillin-resistant Staphylococcusaureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak. J. Am. Acad. Dermatol. 50, 854–858 (2004).

3. Ferrara, A. M. Treatment of hospital-acquired pneumonia caused by methicillin-resistant Staphylococcusaureus. Int. J. Antimicrob. Agents 30, 19–24 (2007).

4. Fowler, V. G. Jr. et al. Staphylococcusaureus endocarditis: a consequence of medical progress. JAMA 293, 3012–3021 (2005).

5. Jensen, A. G., Espersen, F., Skinhoj, P. & Frimodt-Moller, N. Bacteremic Staphylococcusaureus spondylitis. Arch. Intern. Med. 158, 509–517 (1998).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fascaplysin derivatives binding to DNA via unique cationic five-ring coplanar backbone showed potent antimicrobial/antibiofilm activity against MRSA in vitro and in vivo;European Journal of Medicinal Chemistry;2022-02

2. Ginsenoside 20(S)-Rh2 promotes cellular pharmacokinetics and intracellular antibacterial activity of levofloxacin against Staphylococcus aureus through drug efflux inhibition and subcellular stabilization;Acta Pharmacologica Sinica;2021-08-30

3. Levonadifloxacin (WCK 771) exerts potent intracellular activity against Staphylococcus aureus in THP-1 monocytes at clinically relevant concentrations;Journal of Medical Microbiology;2019-12-01

4. The parC mutation G248T (S83I), and concurrent gyrA mutations, are associated with moxifloxacin and sitafloxacin treatment failure for Mycoplasma genitalium;The Journal of Infectious Diseases;2019-10-22

5. Synthesis, structure, photophysical, electrochemical properties and antibacterial activity of brominated BODIPYs as an inhibitor of DNA gyrase B of S. aureus;Journal of Porphyrins and Phthalocyanines;2019-05-28